Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT03559114
PHASE3

PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST)

Sponsor: Sunnybrook Health Sciences Centre

View on ClinicalTrials.gov

Summary

This is a phase III, multi-centre, double blind, randomized controlled trial of patients with traumatic brain injury (TBI).

Official title: PROTEST Trial - PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury, a Double-blind Randomized Controlled Trial

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

1100

Start Date

2018-07-19

Completion Date

2027-12

Last Updated

2024-09-19

Healthy Volunteers

No

Interventions

DRUG

Dalteparin

Dalteparin in prophylactic doses administered daily if screening criteria are satisfied.

DRUG

Saline

Saline in prophylactic doses administered daily if screening criteria are satisfied.

Locations (12)

Foothills Medical Centre

Calgary, Alberta, Canada

Royal Alexandra Hospital

Edmonton, Alberta, Canada

University of Alberta Hospital

Edmonton, Alberta, Canada

Vancouver General Hospital

Vancouver, British Columbia, Canada

Queen Elizabeth II Health Sciences Centre

Halifax, Nova Scotia, Canada

Hamilton Health Sciences Centre

Hamilton, Ontario, Canada

Kingston General Hospital

Kingston, Ontario, Canada

The Ottawa Hospital

Ottawa, Ontario, Canada

Sunnybrook Health Science Centre

Toronto, Ontario, Canada

Unity Health Toronto

Toronto, Ontario, Canada

Hopital de L'Enfant-Jesus

Québec, Quebec, Canada

Royal University Hospital

Saskatoon, Saskatchewan, Canada